AGP Executive Report
Last update: 9 hours agoMedical Travel Update: TSA updated its medical marijuana guidance, clarifying what patients can bring in carry-on and checked bags and urging people to wait until they arrive before using cannabis. Public Health & Safety: UK officials warn about “dangerous” contaminated drugs, including nitazenes reportedly found in seized batches, as overdoses and sudden deaths raise alarm. CBD/Neuro Research: New studies keep pointing to cannabinoids’ potential in brain inflammation and Alzheimer’s models, adding to the growing research thread around CBD-like compounds and neuro health. Clinical Q&A (COPD): A reader asked Dr. Roach about a daily productive cough and marijuana use; he stressed COPD diagnosis needs symptoms plus lab breathing tests, and that spirometer numbers alone don’t confirm lung function. Policy Watch (Psychedelics): Missouri lawmakers pushed to allow psychedelic-assisted therapy clinical trials for veterans, with MDMA-assisted therapy trials highlighted as PTSD-focused momentum. Legal/Access: Kentucky expanded medical cannabis access via executive order, adding qualifying conditions and widening eligibility. Caregiver/Community: A UK recovery charity is raising £1M by having its founder sleep rough across 26 cities to expand addiction treatment capacity.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![Gumitide Gummies [URGENT REPORT 2026] Gumitide Shocking Boom Why Everyone Is Talking About This Weight Loss Gummies](https://ml.globenewswire.com/media/fa2dec49-162d-49d3-b9be-ad7d02b76f1f/medium/gumitide.png)
